Pham Quang X 4
4 · Cadrenal Therapeutics, Inc. · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
Cadrenal Therapeutics (CVKD) 10% Owner Pham Quang Sells 22,385 Shares
What Happened
Pham Quang, a reported 10% owner of Cadrenal Therapeutics (CVKD), sold a total of 22,385 common shares in three open-market transactions between June 8–10, 2026, for aggregate proceeds of about $93,294. Individual transactions reported: 5,893 shares on 2026-06-08 at a weighted avg $4.38 ($25,811), 12,992 shares on 2026-06-09 at a weighted avg $4.06 ($52,748), and 3,500 shares on 2026-06-10 at a weighted avg $4.21 ($14,735). These sales were reported under the sale code (S).
Key Details
- Transaction dates and reported weighted-average prices:
- 2026-06-08: 5,893 sh @ $4.38; weighted price range for these trades reported as $4.20–$4.51 (footnote F2).
- 2026-06-09: 12,992 sh @ $4.06; weighted price range reported as $4.03–$4.34 (footnote F3).
- 2026-06-10: 3,500 sh @ $4.21; weighted price range reported as $4.20–$4.23 (footnote F4).
- Total sold: 22,385 shares for approx. $93,294.
- These sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2025 (footnote F1).
- Ownership/beneficial interest note: The filer is Trustee of The PVBQ Living Trust and has sole voting and dispositive power over shares held by that trust (footnote F5).
- Shares owned after the transactions: Not disclosed in the provided filing details.
- Filing date: Form 4 filed 2026-06-10 covering transactions from 2026-06-08 through 06-10; filing appears timely (no late-filing flag reported).
Context
- These were sales (S) by a 10% owner under a pre-established 10b5-1 plan — a common mechanism that allows scheduled sales and reduces the implication of opportunistic trading. For retail investors, purchases generally signal stronger insider conviction than routine sales; these transactions should be viewed as disposition activity by a large shareholder rather than an explicit endorsement or rejection of company prospects.
- The filing notes weighted-average prices and ranges because each line represents multiple executions; the reporting person has offered to provide transaction-level price details on request.
Insider Transaction Report
Form 4
Pham Quang X
DirectorChairman and CEO10% Owner
Transactions
- Sale
Common Stock
[F1][F2]2026-06-08$4.38/sh−5,893$25,811→ 167,331 total - Sale
Common Stock
[F1][F3]2026-06-09$4.06/sh−12,992$52,748→ 154,339 total - Sale
Common Stock
[F1][F4]2026-06-10$4.21/sh−3,500$14,735→ 150,839 total
Holdings
- 200,000(indirect: By Trust)
Common Stock
[F5]
Footnotes (5)
- [F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.20 through $4.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 through $4.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.20 through $4.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and dispositive power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.
Signature
/s/ Quang X. Pham|2026-06-10